Scleroderma, Systemic: all 695 studies
Page 4 of 7. Open to participants first (224), then studies with results posted, then the rest; newest registration first within each.
- Allogeneic Hematopoietic Cell Transplantation for Severe Systemic SclerosisCompletedNCT00622895Phase 1/2Results posted
- Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic SclerosisCompletedNCT00613171Phase 2Results posted
- Imatinib Mesylate (Gleevec) in the Treatment of Systemic SclerosisCompletedNCT00555581Phase 2Results posted
- A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic SclerosisCompletedNCT00512902Phase 1/2Results posted
- Imatinib in Systemic SclerosisCompletedNCT00506831Phase 1/2Results posted
- High Dose Cyclophosphamide for Treatment of SclerodermaCompletedNCT00501995Phase 3Results posted
- A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's PhenomenonCompletedNCT00498615Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)CompletedNCT00442611Phase 1/2Results posted
- Placebo Controlled Trial of Bosentan in Scleroderma PatientsTerminatedNCT00377455Phase 2Results posted
- Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung InvolvementCompletedNCT00333437Not applicableResults posted
- Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic SclerodermaCompletedNCT00278525Phase 2Results posted
- Scleroderma: Cyclophosphamide or TransplantationCompletedNCT00114530Phase 2/3Results posted
- Scleroderma Lung DiseaseCompletedNCT00004563Phase 3Results posted
- Personalized Online Occupational Therapy Intervention for Adults With SclerodermaCompletedNCT07661836Not applicable
- Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to TreatmentCompletedNCT07542067Phase 1/2
- A Study of BEN301 Injection in theTreatment of Autoimmune DiseasesSuspendedNCT07527936Early Phase 1
- Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With MethotrexateCompletedNCT07472166Phase 4
- Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)CompletedNCT07469865Not applicable
- Self-Guided Resilience-Building Energy Management to Enhance Well-being (RENEW) Intervention for People With Systemic Sclerosis (SSc)CompletedNCT07402863Not applicable
- Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT07361094Phase 1
- the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune DiseasesActive, not recruitingNCT07339540Early Phase 1
- Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease ActivityCompletedNCT07277491
- As Part of a Pilot Study, Visualization of Inflammatory Activity in Systemic Sclerosis Using CXCR4 PET/CTCompletedNCT07212959Not applicable
- UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune DiseasesActive, not recruitingNCT07155369Not applicable
- Color Doppler Ultrasonography Evaluation of Abdominal and Peripheral Vasculopathy in Systemic Sclerosis PatientsCompletedNCT07012655
- Occupational and Environmental Causes of Autoimmune DiseasesCompletedNCT07000903Not applicable
- RENEW-AI: Personalizing Scleroderma Management With an AI Health CoachCompletedNCT06999226Not applicable
- Self-management Telehealth Program for SclerodermaCompletedNCT06990386Not applicable
- Clinical Usefulness and Influence on Esophageal Motility of Pyridostigmine for Dysphagia in Systemic SclerosisWithdrawnNCT06915181Phase 2
- A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune DiseasesWithdrawnNCT06913608Phase 1
- A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT06866080Early Phase 1
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Active, not recruitingNCT06843239Phase 2
- Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic SclerosisSuspendedNCT06792344Phase 1
- Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic SclerosisCompletedNCT06772896Not applicable
- Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in SclerodermaActive, not recruitingNCT06697561Not applicable
- A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic SclerosisActive, not recruitingNCT06655155Phase 2
- A Study of MK-2225 in Healthy Participants (MK-2225-003)CompletedNCT06643390Phase 1
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune DiseaseCompletedNCT06587828
- Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune DiseasesSuspendedNCT06549296Early Phase 1
- A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic DiseaseActive, not recruitingNCT06544330Phase 1
- Validity and Reliability of the Turkish Version of HAnDECompletedNCT06536595
- Exercise With Scleroderma Functional OutcomesCompletedNCT06425653Not applicable
- KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic SclerosisTerminatedNCT06400303Phase 1/2
- A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)WithdrawnNCT06377228Phase 1
- Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1CompletedNCT06373263Not applicable
- Making it Work Program for Systemic SclerosisCompletedNCT06338722Not applicable
- Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic SclerosisActive, not recruitingNCT06333795Not applicable
- Early Diagnosis of SSc in the General Rheumatology Clinic - PilotCompletedNCT06291142
- A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune DiseasesActive, not recruitingNCT06255028Phase 1
- Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic SclerosisCompletedNCT06231433Phase 2/3
- Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic SclerosisSuspendedNCT06210945Phase 2
- The Effect of a Self-Management Program on Individuals With SclerodermaCompletedNCT06095921Not applicable
- Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male SubjectsCompletedNCT06037577Phase 1
- PortoSinusoidal Vascular Diseases and Systemic SclerosisCompletedNCT06032754
- Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune DiseasesActive, not recruitingNCT06029335
- Rituxmab Versus IL-6 in Treating ILDCompletedNCT05963048Phase 2/3
- Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory RheumatismCompletedNCT05961267
- Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)Active, not recruitingNCT05925803Phase 3
- Ultrasound Therapy and Manual Therapy in Digital Ischemic UlcersCompletedNCT05907200Not applicable
- Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic DiseasesActive, not recruitingNCT05879419Phase 4
- A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Active, not recruitingNCT05869955Phase 1
- Co-designing Digital Ulcers Opportunities With Patients and CliniciansStatus unknownNCT05785403
- Klotho and Mineral Bone Density in Systemic SclerosisCompletedNCT05777954
- Clinical Study of Divozilimab in Patients With Systemic SclerodermaActive, not recruitingNCT05726630Phase 3
- Rheumatology-based Adaptive Intervention for Social Determinants and Health EquityActive, not recruitingNCT05715463Not applicable
- Longitudinal Spatial Frequency Domain Imaging StudyActive, not recruitingNCT05672992Not applicable
- Sleep Quality, Stress, Depression, Blood Pressure Responses to Diaphragmatic Respiratory Exercise in Systemic SclerosisStatus unknownNCT05623917Not applicable
- Phenotyping of Chronic Pain in Diffused Systemic SclerodermaCompletedNCT05622578Not applicable
- Stress, Scleroderma and Quality of LifeCompletedNCT05617066Not applicable
- A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis SymptomsCompletedNCT05559580Phase 2
- Personalized Home Respiratory Rehabilitation Program for Subjects With Systemic Sclerosis With Early Lung DiseaseCompletedNCT05533034Not applicable
- Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic SclerosisCompletedNCT05528809Not applicable
- Nitric Oxide Lung Diffusing Capacity in Systemic SclerosisCompletedNCT05505617
- Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?Status unknownNCT05482594
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic SclerosisCompletedNCT05462522Phase 1
- The Effect of Cognitive Exercise Therapy Approach in Individuals With Systemic SclerosisCompletedNCT05453071Not applicable
- Effectiveness of Cannabinoids on Appetite in SclerodermaCompletedNCT05416697Phase 3
- Novel Splinting Technique Using 3D ModelsStatus unknownNCT05351060Not applicable
- A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic SclerosisActive, not recruitingNCT05300932Phase 4
- RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic SclerosisTerminatedNCT05298358Phase 1
- Structural and Functional Impairment of Multiple Organs in Patients With Systemic Sclerosis: A MR Imaging StudyStatus unknownNCT05297474
- COvid-19 Vaccine Booster in Immunocompromised Rheumatic DiseasesStatus unknownNCT05236491Phase 2/3
- Exercise in People With Systemic SclerosisCompletedNCT05234671Not applicable
- Treatment of Systemic Sclerosis With Autologous Regulatory Т-cellsStatus unknownNCT05214014Phase 1/2
- Rheopheresis for Raynaud's and Digital Ulcers in Systemic SclerosisStatus unknownNCT05204784Not applicable
- A Study of MT-0551 in Patients With Systemic SclerosisActive, not recruitingNCT05198557Phase 3
- Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma.TerminatedNCT05181644Not applicable
- Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung DiseaseWithdrawnNCT05177471
- Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.CompletedNCT05171114Not applicable
- Open Label Extension Study of Brentuximab Vedotin in Early dcSScCompletedNCT05149768Phase 2
- Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis PatientsStatus unknownNCT05105217
- A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic SclerosisWithdrawnNCT05098145Phase 1/2
- A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory SclerodermaStatus unknownNCT05085444Early Phase 1
- Upper Extremity Home Exercises in Patients With SclerodermaCompletedNCT05080738Not applicable
- The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic SclerosisStatus unknownNCT05078749Not applicable
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic SclerosisTerminatedNCT05016804Phase 1
- Skin Fibrosis Analysis by Raman Spectroscopy in Systemic SclerosisCompletedNCT04996082
- Systemic Sclerosis and Innate T CellsCompletedNCT04995588Not applicable
- Implementation of a Biological Sample Collection in Systemic Sclerosis PatientsWithdrawnNCT04986514
- Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic SclerosisCompletedNCT04971018Not applicable